A recent dinner and symposium hosted by the Society of Nuclear Medicine and Molecular Imaging featured presentations by a multidisciplinary UCSF team on the topic of amyloid PET imaging, a diagnostic technique to diagnose Alzheimer's disease.
Alzheimer’s disease is the most common form of dementia, accounting for approximately 50 to 70 percent of all cases, yet there are still many complexities involved in diagnosing the disease. Amyloid PET imaging represents a potentially revolutionary advancement in the assessment of those with cognitive impairment.
Although traumatic brain injury is often a hidden injury, it is of epidemic proportions affecting millions of Americans. TBI is the “signature injury” of the wars in Iraq and Afghanistan, but Alisa Gean-Gersch, MD has worked for decades to improve care for those suffering from TBI.
Spurred by a lifelong interest in the human nervous system, Jim Barkovich, MD's work in optimizing techniques for studying normal and abnormal brain development in infants and children has been described as “visionary,” “pioneering” and “ground-breaking.”
Submitted by econnor on February 23, 2016 - 12:49pm
Together, The Global Alzheimer’s Platform Foundation and the Brain Health Registry aim to add tens of thousands of potential Alzheimer's clinical trial candidates to the global registry and accelerate a treatment for Alzheimer's disease.
Submitted by econnor on February 19, 2016 - 1:58pm
A collaborative planning meeting between UCSF's Departments of Radiology and Psychiatry was the first step towards enhanced collaboration between the two groups in order to better serve patients clinically through advancing neurological research.
The Brain Health Registry, a groundbreaking, web-based project led by UCSF researchers designed to speed up cures for Alzheimer’s, Parkinson’s and other brain disorders, has a new face.
